Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Relapse Prevention in Stimulant Use Disorder

NCT04553263 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT04553263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04553263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Relapse Prevention in Stimulant Use Disorder
Lead sponsor
University of California, Los Angeles
Phase
Phase 1
Overall status
Withdrawn
Start date
June 11, 2023
Completion date
January 11, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adhd, cognitive function, relapse, stimulant use